
Giorgio Minotti
Articles
-
Jul 1, 2024 |
jacc.org | Massimiliano Camilli |Carlo Maria Cipolla |Susan Dent |Giorgio Minotti
Introduction Since the 1980s, anthracyclines, including doxorubicin, daunorubicin, epirubicin, and idarubicin, have been central to treating various hematologic and solid malignancies, such as Hodgkin lymphoma (HL), non-Hodgkin lymphoma (nHL), acute leukemias, breast cancer (BC), ovarian cancer, and sarcomas.1,2 In clinical practice, the application of anthracyclines is limited by a dose-dependent cardiotoxicity, leading to both systolic and diastolic cardiac dysfunction and, in less common...
-
Oct 9, 2023 |
jpet.aspetjournals.org | Giorgio Minotti |Massimiliano Camilli
High plasma levels of low-density lipoprotein cholesterol (LDL-C) have long been known to associate with a measurable increase of cardiovascular (CV) events in the general population. LDL-C lowering drugs, from the venerable statins to ezetimibe and PCSK9 inhibitors, are therefore pillars of the clinical management of patients with high LDL-C, but the magnitude of reduction of CV events in the at-risk patients remains a matter of controversy.
-
Jul 18, 2023 |
pubmed.ncbi.nlm.nih.gov | Giorgio Minotti
Skip to main page content Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day?
-
Jul 17, 2023 |
jpet.aspetjournals.org | Giorgio Minotti
EditorialSpecial Section on Clinical Pharmacology—Editorial A Special Section on Clinical Pharmacology—Editorial Journal of Pharmacology and Experimental Therapeutics August 2023, 386 (2) 115-116; DOI: https://doi.org/10.1124/jpet.123.001743
-
Feb 24, 2023 |
jpet.aspetjournals.org | Giorgio Minotti
The March issue of the Journal of Pharmacology and Experimental Therapeutics offers an interesting read on palonosetron for managing nausea and vomiting in beagle dogs treated with the anticancer agent cisplatin (Levijoki et al., 2023). The subject matter is anything but novel.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →